Doceree Launches HIPAA-Compliant Site LLM

Doceree Launches HIPAA-Compliant Site LLM

Admanager by Doceree unveils Site LLM, a private, HIPAA-compliant AI assistant built to help healthcare publishers retain traffic and monetize engagement.

Admanager, powered by Doceree, has introduced Site LLM, a private, HIPAA-compliant AI assistant designed to help healthcare publishers counter the growing impact of generative AI on search traffic and revenue.

The product, launched from Short Hills, N.J., is the flagship component of the company’s Publisher AI Suite. Unlike general-purpose AI tools that intercept user queries before they reach source websites, Site LLM is deployed directly within a publisher’s own domain and trained exclusively on that publisher’s peer-reviewed medical content.

AI Search and the Traffic Squeeze

The launch comes as healthcare publishers confront a structural shift in search behavior. According to company data, 69 percent of health-related queries are now answered by AI-generated overviews before users click through to publisher sites. Meanwhile, 63 to 85 percent of Google searches end without a click.

The result has been significant declines in click-through rates — in some cases between 34 and 46 percent across key healthcare categories — along with year-over-year revenue contractions ranging from 15 to 29 percent.

Compounding the problem, publishers face escalating bot traffic and content scraping. Roughly half of web traffic is now non-human, the company said, with a substantial share attributed to bots harvesting editorial content for AI training.

Site LLM is intended as a countermeasure.

A Closed, Publisher-Controlled AI

The assistant is trained exclusively on verified, publisher-owned medical content and operates entirely within the publisher’s infrastructure. It does not draw from external sources, share data externally or redirect users to third-party AI platforms.

“Publishers created the content that trained the AI ecosystem,” said Harshit Jain, founder and global chief executive of Doceree. “Site LLM gives publishers something powerful: an AI that strengthens their platform rather than siphoning value away from it.”

The system is designed to increase session duration by providing personalized, clinically accurate responses directly on-site. It also offers an audit trail, zero external data leakage and compliance with HIPAA requirements — critical in regulated healthcare environments.

Also Read: Brands Turn First-Party Data Into Revenue

Monetization Built In

Site LLM integrates with AI Ads, a contextual advertising format embedded within AI-powered medical conversations. The broader Publisher AI Suite also includes an AI Licensing Marketplace, intended to provide structured frameworks for publishers to license and monetize content access to AI developers, pharmaceutical companies and continuing medical education providers.

“Healthcare publishers who embed AI into their infrastructure — on their terms — will define the next chapter of medical media,” said Varun Hasija, vice president of product and innovation (AI).

As generative AI reshapes clinical search and information discovery, Site LLM represents a strategic pivot: transforming AI from a traffic threat into an on-domain engagement engine controlled by publishers themselves.